首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.
【24h】

Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.

机译:来自斯里兰卡的 1 型糖尿病患者的胰岛细胞、甲状腺、肾上腺和乳糜泻相关自身抗体。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIMS: The prevalence of islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes mellitus (Type 1 DM) from Sri Lanka is described. DESIGN AND METHODS: Autoantibodies to glutamic acid decarboxylase 65 (GAD65Ab), protein tyrosine phosphatase IA-2 (IA-2Ab), insulin (IAAb), thyroglobulin (TgAb), thyroid peroxidase (TPOAb), TSH receptor (TRAb), 21-hydroxylase (21-OHAb) and tissue transglutaminase (tTGAb) were measured in 122 Type 1 DM patients who had low C-peptide activity or were >20 yr old at the time of diagnosis and in 100 non-diabetic blood donors. RESULTS: GAD65Ab and/or IA-2Ab were present in 74/122 (60.7) Type 1 DM subjects with a significantly higher prevalence compared to non-diabetic controls (no. 100) (GAD65Ab-59 vs 4; IA-2Ab-14 vs 0; respectively) (p or =5 yr (19 vs 4) (p<0.001). There was no difference in the prevalence of TgAb (25 vs 33)(p=0.21) and TPOAb (22 vs 18) (p=0.48) in Type 1 DM and non-diabetic subjects. Also, there was no difference in TgAb and TPOAb prevalence in antibody positive Type 1 DM (34.7) compared to antibody negative Type 1 DM (24.4) subjects (p=0.24). tTGAb (3/119) and TRAb (1/119) were found in low prevalence and 21-OHAb were not detected. CONCLUSIONS: Diabetes associated autoantibodies were detected in the majority of Type 1 DM subjects, suggesting a major role for autoimmunity in the pathogenesis of Type 1 DM in Sri Lankans. The prevalence of TgAb and TPOAb in Type 1 DM subjects and non-diabetic controls was relatively high and similar in both groups.
机译:目的:描述了来自斯里兰卡的 1 型糖尿病(1 型糖尿病)患者胰岛细胞、甲状腺、肾上腺和乳糜泻相关自身抗体的患病率。设计和方法: 在 122 名 C 肽活性低或诊断时年龄为 >20 岁的 1 型糖尿病患者和 100 名非糖尿病献血者中测量了谷氨酸脱羧酶 65 (GAD65Ab)、蛋白酪氨酸磷酸酶 IA-2 (IA-2Ab)、胰岛素 (IAAb)、甲状腺球蛋白 (TgAb)、甲状腺过氧化物酶 (TPOAb)、TSH 受体 (TRAb)、21-羟化酶 (21-OHAb) 和组织谷氨酰胺转氨酶 (tTGAb) 的自身抗体。结果:GAD65Ab 和/或 IA-2Ab 存在于 74/122 (60.7%) 1 型 DM 受试者中,与非糖尿病对照组(第 100 名)相比,患病率显着更高(GAD65Ab-59 vs 4%;IA-2Ab-14 与 0%;(p或=5年而降低(19 vs 4%)(p<0.001)。在1型糖尿病和非糖尿病受试者中,TgAb(25 vs 33%)(p=0.21)和TPOAb(22 vs 18%)(p=0.48)的患病率没有差异。此外,抗体阳性 1 型 DM (34.7%) 的 TgAb 和 TPOAb 患病率与抗体阴性的 1 型 DM 受试者 (24.4%) 没有差异 (p=0.24)。tTGAb (3/119) 和 TRAb (1/119) 患病率较低,未检测到 21-OHAb。结论:在大多数 1 型糖尿病受试者中检测到糖尿病相关自身抗体,表明自身免疫在斯里兰卡人 1 型糖尿病的发病机制中起主要作用。TgAb 和 TPOAb 在 1 型糖尿病受试者和非糖尿病对照组中的患病率相对较高且相似。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号